Pharmacologic theraphy for acute myocardial infarction: Which agent, how much, how soon, how long?

Postgraduate Medicine

Volumn 102, Issue 5, 1997, Pages 143-157

  Rapaport, Elliot ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CARDIAC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GLYCERYL TRINITRATE; ISOSORBIDE MONONITRATE; LISINOPRIL; MAGNESIUM; NITRATE; PLACEBO; ZOFENOPRIL;

ACUTE HEART INFARCTION; ANGINA PECTORIS; CLINICAL TRIAL; CONFERENCE PAPER; DRUG CONTRAINDICATION; DRUG INDICATION; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MORTALITY; ORAL DRUG ADMINISTRATION; SUBLINGUAL DRUG ADMINISTRATION; TRANSLUMINAL CORONARY ANGIOPLASTY; HEART INFARCTION; REVIEW;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; CLINICAL TRIALS; HUMANS; MYOCARDIAL INFARCTION; NITROGLYCERIN; PLATELET AGGREGATION INHIBITORS;

EID: 0031279122     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1997.11.364     Document Type: Conference Paper

References (17)

1. Roberts R. Intravenous nitroglycerin in acute myocardial infarction. Am J Med 1983;74(6B):45-52
2. Yusuf S, Collins R, MacMahon S, et al. Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials. Lancet 1988;1(8594):1088-92
3. Jugdutt BI, Warnica JW. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications: effect of timing, dosage, and infarct location. Circulation 1988;78(4):906-19 [Erratum, Circulation 1989;79(5):1151]
4. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995;345(8951):669-85
5. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryltrinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994;343(8906): 1115-22
6. Woods KL. Mega-trials and management of acute myocardial infarction. Lancet 1995;346(8975):611-4
7. Yusuf S, Sleight P, Held P, et al. Routine medical management of acute myocardial infarction: lessons from overviews of recent randomized controlled trials. Circulation 1990;82(Suppl II):117-34-II
8. Lewis HD Jr. Unstable angina: status of aspirin and other forms of therapy. Circulation 1985;72(Suppl V):155-60-V
9. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2(8607):349-60
10. First International Study of Infarct Survival Collaborative Group. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 1986;2(8498):57-66
11. Yusuf S, Anand S, Avezum A Jr, et al. Treatment for acute myocardial infarction: overview of randomized clinical trials. Eur Heart J 1996;17(Suppl F):16-29
12. Roberts R, Rogers WJ, Mueller HS, et al. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. Circulation 1991;83(2):422-37
13. Rapaport E. Should beta-blockers be given immediately and concomitantly with thrombolytic therapy in acute myocardial infarction? (Editorial) Circulation 1991;83(2):695-7
14. Swedberg K, Held P, Kjekshus J, et al. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med 1992; 327(10):678-84
15. Ambrosioni E, Borghi C, Magnani B, for the Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med 1995;332(2):80-5
16. Chinese Cardiac Study Collaborative Group. Oral captopril versus placebo among 13634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1). Lancet 1995;345(8951):686-7
17. Borghi C, Ambrosioni E. Clinical aspects of ACE inhibition in patients with acute myocardial infarction. Cardiovasc Drugs Ther 1996;10(5):519-25